Matching geography
Reports matching your search in:
 
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
Region: All Regions > Africa
Category: All Categories > Life Sciences > Healthcare
(148 reports matching your criteria)
 
< prev 1    3  4  5  6  
Ghana Pharmaceuticals and Healthcare Report Q2 2014
4/2/2014 | published by: Business Monitor International
... and pharmaceuticalmarkets over the long term. This is due to the government's commitment to the National Health InsuranceScheme, which is recognised as one of the best in the region, and currently covers over 36% of ...  |  read more...
$1,295.00
Egypt Pharmaceuticals and Healthcare Report Q2 2014
3/19/2014 | published by: Business Monitor International
... some localdrug production, ongoing strikes by doctors and calls for improvements to the registration and pricingregime for pharmaceuticals. Despite its favourable demographic and epidemiological profile, the Egyptianpharmaceutical market has a relatively weak outlook for growth, ...  |  read more...
$1,295.00
Understanding South Africa’s Regional Healthcare Markets
3/14/2014 | published by: Espicom Healthcare Intelligence
... be seen at the varied regional and provincial levels? Any assessment of South Africa must consider the potential variations across Eastern Cape, Free State, Gauteng, KwaZulu-Natal, Limpopo, Mpumalanga, North West, Northern Cape and Western Cape, ...  |  read more...
$935.00
Uganda Pharmaceuticals and Healthcare Report Q2 2014
3/12/2014 | published by: Business Monitor International
... will beslow due to the limited capabilities of local pharmaceutical companies, which are unable to compete withthe greater range of medicines made by multinational generic drugmakers. Headline Expenditure Projections Pharmaceuticals: UGX824.35bn (US$320mn) in 2013 to ...  |  read more...
$1,295.00
Zimbabwe Pharmaceuticals and Healthcare Report Q2 2014
3/12/2014 | published by: Business Monitor International
... lack ofaccess to medical treatment has led to a large proportion of the population becoming more reliant onherbal and traditional medicine, which has seen a recent influx in the country. However, with theZimbabwean authorities pushing ...  |  read more...
$1,295.00
Zambia Pharmaceuticals and Healthcare Report Q2 2014
2/26/2014 | published by: Business Monitor International
... a reduction inbureaucracy, the decentralisation of healthcare provision, investment in human resources and equipment,and a laboratory to improve the quality of drugs in the country, which has attracted significantinternational investment. Headline Expenditure Projections Pharmaceuticals: ZMK1,121bn ...  |  read more...
$1,295.00
Tanzania Pharmaceuticals and Healthcare Report Q2 2014
2/26/2014 | published by: Business Monitor International
... Additionally, export growthwill be slow due to the limited capabilities of local drugmakers, which are unable to compete with thegreater range of medicines made by multinational generic medicine firms. Headline Expenditure Projections Pharmaceuticals: TZS533.15bn (US328mn) ...  |  read more...
$1,295.00
Cameroon Pharmaceuticals and Healthcare Report Q2 2014
2/21/2014 | published by: Business Monitor International
... attract investment fromforeign pharmaceutical firms. In addition to low spending, issues such as corruption and relatively sloweconomic growth will also limit the country's attractiveness. Headline Expenditure Projections Pharmaceuticals: XAF148.82bn (US$300mn) in 2013 to XAF167.12bn (US$320mn) ...  |  read more...
$1,295.00
Botswana Pharmaceuticals and Healthcare Report Q2 2014
2/21/2014 | published by: Business Monitor International
... of the sector. In addition, the overall Sub-Saharan Africa region has low expenditure onhealthcare and pharmaceutical, making it less likely that firms will invest in the region. Headline Expenditure Projections Pharmaceuticals: BWP1.60bn (US$193mn) in 2013 ...  |  read more...
$1,295.00
Cote d'Ivoire Pharmaceuticals and Healthcare Report Q2 2014
2/21/2014 | published by: Business Monitor International
... to multinationals looking to launchinnovative products in Africa. This is due to risks in its pharmaceutical environment, which include poorpatent respect, lack of policy enforcement and approvals expediency, as well as a weak business setting. ...  |  read more...
$1,295.00
Gabon Pharmaceuticals and Healthcare Report Q2 2014
2/21/2014 | published by: Business Monitor International
... patientsand prescribers. As economies in non-traditional markets such as Gabon evolve, more funds will be madeavailable for the diagnosis and treatment of these diseases. Only companies with an understanding of theinherent challenges present will be ...  |  read more...
$1,295.00
Sudan Pharmaceuticals and Healthcare Report Q2 2014
2/21/2014 | published by: Business Monitor International
... to a variety of reasons,some of which are industry-specific (eg, Sudan's failure to pay and lack of patent respect) and otherscountry-specific (such as extensive bureaucracy, rampant corruption and unrests). Consequently, we do notexpect the market ...  |  read more...
$1,295.00
Mozambique Pharmaceuticals and Healthcare Report Q2 2014
2/12/2014 | published by: Business Monitor International
... increasing demands onpharmaceutical products and healthcare services. Drug scarcity is commonplace due to distributionproblems, and a wide gap between the quality of healthcare provisions in urban and rural areas still exists,with the latter lagging far ...  |  read more...
$1,295.00
Angola Pharmaceuticals and Healthcare Report Q2 2014
2/12/2014 | published by: Business Monitor International
... to oil prices. The healthcare sector still remains tobe improved where communicable diseases such as HIV/AIDS, dengue and malaria continue to account fora large portion of the burden of disease. Rich in natural resources, the ...  |  read more...
$1,295.00
Namibia Pharmaceuticals and Healthcare Report Q2 2014
2/12/2014 | published by: Business Monitor International
... increase the proportion of fiscal expenditure devoted to healthcare) and private (as economiesgrow and per capita wealth increases) sectors and improved access to health facilities - as well as agrowing awareness of preventative healthcare and ...  |  read more...
$1,295.00
Kenya Pharmaceuticals and Healthcare Report Q2 2014
2/5/2014 | published by: Business Monitor International
... in a market that hastraditionally focussed on infectious diseases such as malaria, tuberculosis and HIV. Besides challengesrelated to diagnosis, care and treatment, there is a lack of understanding and knowledge about diseasessuch as diabetes and ...  |  read more...
$1,295.00
Nigeria Pharmaceuticals and Healthcare Report Q2 2014
2/5/2014 | published by: Business Monitor International
... improve healthcare access. Rising demand for medicines will see drugmakersincrease their presence and continue to expand. However, ructions within the ruling party, poor drug patentprotection and the likelihood of further divestment in the oil and ...  |  read more...
$1,295.00
Algeria Pharmaceuticals and Healthcare Report Q2 2014
2/5/2014 | published by: Business Monitor International
... thecapacity of its local pharmaceutical industry and reduce reliance on imported medicines. These includeSaidal's detailing of an aggressive investment plan in a number of manufacturing facilities over the mediumterm and a decline in total pharmaceutical ...  |  read more...
$1,295.00
Health and Wellness Tourism in Morocco
1/17/2014 | published by: Euromonitor International
... has more than 80 plastic surgeons operating in more than 15 clinics located all over the kingdom. Most of these clinics are in Casablanca and Marrakech and the prices of a plastic surgery range between ...  |  read more...
$900.00
South Africa Pharmaceuticals and Healthcare Report Q1 2014
1/8/2014 | published by: Business Monitor International
... ongoingdepreciation of the South African Rand against hard currencies will have a negative impact on the volumeof medicines in circulation. Nevertheless, we believe favourable demographics and the large market sizewill continue to attract foreign drugmakers ...  |  read more...
$1,295.00
Morocco Pharmaceuticals and Healthcare Report Q1 2014
1/1/2014 | published by: Business Monitor International
... and multiple strains on householdincomes weaken domestic demand. This is combined with access to finance remaining difficult for localdrugmakers. However, we hold a broadly positive outlook for the sector over the long-term as the roll-out ...  |  read more...
$1,295.00
Morocco Healthcare & Pharmaceuticals
12/1/2013 | published by: Noozz Research
... Moroccan government is in the process of increasing free healthcare services, particularly for those living under and around the poverty line as well as those living in rural areas. However, private care is engrained in ...  |  read more...
$450.00
Middle East North Africa Pharmaceutical Market Forecasts to 2018
11/26/2013 | published by: Espicom Healthcare Intelligence
... East North Africa fit into this global outlook? This analysis report, Middle East North Africa Pharmaceutical Market Forecasts to 2018 (published November 2013), is an essential resource for business forecasters, marketing planners, the investment community ...  |  read more...
$1,495.00
Health and Wellness Tourism in Kenya
11/6/2013 | published by: Euromonitor International
... the growing conference and business tourism segment, whilst already established brands such as InterContinental and Hilton are seeking to increase their presence within the city in order to meet the growing demand for tourist accommodation. ...  |  read more...
$900.00
Healthcare Buildings Construction in South Africa to 2017: Market Databook
9/20/2013 | published by: Timetric
... activity (new construction, repair and maintenance, refurbishment and demolition). The databook provides historical and forecast valuations of the industry using the construction output and value-add methods. Summary This report is the result of Timetric’s extensive ...  |  read more...
$500.00
< prev 1    3  4  5  6